{"drugs":["Histamine Phosphate","Histatrol"],"mono":{"0":{"id":"283580-s-0","title":"Generic Names","mono":"Histamine Phosphate"},"1":{"id":"283580-s-1","title":"Dosing and Indications","sub":{"0":{"id":"283580-s-1-4","title":"Adult Dosing","mono":"<ul><li><b>Asthma; Diagnosis:<\/b> nebulized, sequentially increasing concentrations of 0.03-10 mg\/mL INHALED in 5 slow deep breaths, each separated by 3-5 minutes<\/li><li><b>Gastric histamine test:<\/b> 0.0275 mg\/kg histamine phosphate subQ<\/li><li><b>Gastric histamine test:<\/b> augmented test, 0.04 mg\/kg subQ following administration of a suitable dose of antihistamine<\/li><\/ul>"},"1":{"id":"283580-s-1-5","title":"Pediatric Dosing","mono":"<ul><li>Not FDA approved in children<\/li><li><b>Asthma; Diagnosis:<\/b> 0.1-10 mg\/mL INHALED, using the tidal breathing method.<\/li><\/ul>"},"3":{"id":"283580-s-1-7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><br\/>Positive skin test reaction, control<br\/><b>Non-FDA Labeled Indications<\/b><ul><li>Asthma; Diagnosis<\/li><li>Gastric histamine test<\/li><\/ul>"}}},"3":{"id":"283580-s-3","title":"Contraindications\/Warnings","sub":[{"id":"283580-s-3-9","title":"Contraindications","mono":"<ul><li>bronchial asthma<\/li><li>hypersensitivity to histamine products<\/li><li>hypotension<\/li><li>severe cardiac, pulmonary, or renal disease<\/li><li>severe hypertension<\/li><li>urticaria (past or present)<\/li><li>vasomotor instability<\/li><\/ul>"},{"id":"283580-s-3-10","title":"Precautions","mono":"<ul><li>allergic diseases<\/li><li>bronchial disease (may precipitate asthma)<\/li><li>cardiac abnormality<\/li><\/ul>"},{"id":"283580-s-3-11","title":"Pregnancy Category","mono":"Histamine: Fetal risk cannot be ruled out. (TH)<br\/>"},{"id":"283580-s-3-12","title":"Breast Feeding","mono":"Histamine: Micromedex: Infant risk cannot be ruled out.<br\/>"}]},"5":{"id":"283580-s-5","title":"Adverse Effects","mono":"<b>Common<\/b><ul><li><b>Cardiovascular:<\/b>Hypertension, Hypotension, Tachyarrhythmia<\/li><li><b>Dermatologic:<\/b>Flushing<\/li><li><b>Gastrointestinal:<\/b>Diarrhea, Metallic taste, Stomach cramps<\/li><li><b>Neurologic:<\/b>Headache<\/li><\/ul><b>Serious<\/b><br\/><b>Respiratory:<\/b>Stenosis of bronchus<br\/>"},"6":{"id":"283580-s-6","title":"Drug Name Info","sub":{"0":{"id":"283580-s-6-17","title":"US Trade Names","mono":"Histatrol<br\/>"},"2":{"id":"283580-s-6-19","title":"Class","mono":"Diagnostic Agent<br\/>"},"3":{"id":"283580-s-6-20","title":"Regulatory Status","mono":"RX<br\/>"},"4":{"id":"283580-s-6-21","title":"Generic Availability","mono":"No<br\/>"}}},"7":{"id":"283580-s-7","title":"Mechanism Of Action","mono":"Histamine phosphate is a potent drug that causes relaxation and vasodilation of the blood vessels during an allergic reaction.<br\/>"},"9":{"id":"283580-s-9","title":"Administration","mono":"<ul><li><b>General Information<\/b><br\/>the test should be read in 15 min<br\/><\/li><li><b>Intradermal<\/b><br\/><ul><li>(skin test) administer at a maximum concentration of histamine base 0.1 mg\/mL (histamine phosphate 0.275 mg\/mL); or dilute ten-fold to 0.01 mg\/mL of histamine base<\/li><li>(skin test) inject on the arm or back at the same site with the other skin test allergens<\/li><li>(percutaneous (prick, puncture, scratch test)) administer at concentration of histamine base 1 mg\/mL (histamine phosphate 2.75 mg\/mL)<\/li><li>(percutaneous (prick, puncture, scratch test)) inject on the back or the volar surface of the forearm at the same site with the other skin test allergens<\/li><\/ul><\/li><\/ul>"},"10":{"id":"283580-s-10","title":"Monitoring","mono":"<ul><li>size of erythema and\/or wheal<\/li><li>blood pressure, respiratory function<\/li><\/ul>"},"11":{"id":"283580-s-11","title":"How Supplied","mono":"<b>Histatrol<\/b><br\/><ul><li>Intradermal Solution: 0.275 MG\/ML<\/li><li>Topical Solution: 2.75 MG\/ML<\/li><\/ul>"},"13":{"id":"283580-s-13","title":"Clinical Teaching","mono":"<ul><li>This drug may cause hypertension, flushing, diarrhea, metallic taste, stomach cramps, or headache.<\/li><li>Patient should report signs\/symptoms of tachyarrhythmia or hypotension.<\/li><\/ul>"}}}